Mycobacterium tuberculosis Protein Ag85A-CD8 is a peptide derived from Ag85A used to study CD8⁺ T-cell recognition. Its sequence allows characterization of peptide–MHC binding parameters. Researchers employ it to investigate cellular immune responses to mycobacterial antigens. The peptide aids epitope mapping and vaccine-relevant immunology research.
CAT No: B01004
1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
2. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More